Abstract: A system and method for managing a tractor-trailer and a method are provided. The system includes: a control server to manage a position of a trailer, identification information on the trailer, and identification information on a tractor matched to the trailer with respect to each hub; a trailer to authenticate the tractor by comparing the identification information, which is received from the control server, on the tractor, with identification information received from the tractor, and to release an electronic parking brake (EPB) when an authentication result for the tractor is correct; and a tractor to authenticate the trailer by comparing the identification information, which is received from the control server, on the trailer with identification information received from the trailer to authenticate the trailer, and to be coupled to the trailer, when an authentication result for the trailer is correct.

Abstract: Disclosed are a Filipendula glaberrima alcoholic extract and solvent fractions fractionated therefrom or novel compounds 1 and 2 purely isolated from a Filipendula glaberrima ethyl acetate fraction that have an excellent inhibitory effect against HMG-CoA reductase activity, an excellent antioxidant effect and a remarkably excellent effect of suppressing the formation of foam cells in macrophages. Also, disclosed is a pharmaceutical composition or health food composition for treating, preventing and ameliorating vascular diseases, hypercholesterolemia, or heart diseases caused by hypercholesterolemia, or lowering blood cholesterol levels, containing, as active ingredients, the Filipendula glaberrima alcoholic extract and the solvent fractions or the novel compounds 1 and 2.

Abstract: A method, a composition and a kit for screening an ALK or ROS-1 kinase inhibitor are disclosed in the present specification. In an aspect, by the method, composition and kit for screening an ALK or ROS-1 kinase inhibitor according to the present disclosure, it is possible to conduct simultaneous quantitative and qualitative analysis and faster screening of a larger number of candidate substances as compared with conventional molecular biological experimental methods and to grasp the overall level of change in a plurality of different metabolites in a cell line by candidate substances of ALK or ROS-1 kinase inhibitor and thus the screening efficiency for drugs which exert an ALK or ROS-1 kinase inhibitory effect is excellent. Consequently, the present disclosure has an advantage of being able to be used in various ways in the development of new drugs which exert an ALK or ROS-1 kinase inhibitory effect.

Abstract: Disclosed are a Filipendula glaberrima alcoholic extract and solvent fractions fractionated therefrom or novel compounds 1 and 2 purely isolated from a Filipendula glaberrima ethyl acetate fraction that have an excellent inhibitory effect against HMG-CoA reductase activity, an excellent antioxidant effect and a remarkably excellent effect of suppressing the formation of foam cells in macrophages. Also, disclosed is a pharmaceutical composition or health food composition for treating, preventing and ameliorating vascular diseases, hypercholesterolemia, or heart diseases caused by hypercholesterolemia, or lowering blood cholesterol levels, containing, as active ingredients, the Filipendula glaberrima alcoholic extract and the solvent fractions or the novel compounds 1 and 2.

Abstract: A method, a composition and a kit for screening an ALK or ROS-1 kinase inhibitor are disclosed in the present specification. In an aspect, by the method, composition and kit for screening an ALK or ROS-1 kinase inhibitor according to the present disclosure, it is possible to conduct simultaneous quantitative and qualitative analysis and faster screening of a larger number of candidate substances as compared with conventional molecular biological experimental methods and to grasp the overall level of change in a plurality of different metabolites in a cell line by candidate substances of ALK or ROS-1 kinase inhibitor and thus the screening efficiency for drugs which exert an ALK or ROS-1 kinase inhibitory effect is excellent. Consequently, the present disclosure has an advantage of being able to be used in various ways in the development of new drugs which exert an ALK or ROS-1 kinase inhibitory effect.

Abstract: The disclosure is related tracking area management in a femtocell network. A mobility management entity may receive, from a femtocell base station, macrocell tracking area information associated with the femtocell base station. The mobility management entity may combine the received macrocell tracking area information with femtocell tracking area information associated with the femtocell base station and storing the combined tracking area information as integrated tracking area information.

Abstract: Described embodiments provide for handover in a long term evolution (LTE) communication network. A LTE macrocell base station may receive a measurement report from user equipment while providing a communication service to the user equipment located within a service area of the LTE macrocell base station, and determine whether or not the neighbor cell is a LTE macrocell or a LTE femtocell based on the measurement report. The LTE macrocell base station may initiate hand-over of the user equipment to a neighbor WCDMA macrocell base station when the neighbor cell is determined as the LTE femtocell.

Abstract: Provided are apparatus and method for setting a cyclic prefix length according to a type of a base station. The apparatus may include a memory, a receiver, a selector, and an inserter. The receiver may be configured to store and to manage a plurality of prefix lengths associated with base station types. The receiver may be configured to receive base station information from a base station. The selector may be configured to select a prefix length from the plurality of prefix length based on the received base station information. The inserter may be configured to insert a cyclic prefix having the determined prefix length in a guard interval of a transmission frame.

Abstract: The disclosure is related tracking area management in a femtocell network. A mobility management entity may receive, from a femtocell base station, macrocell tracking area information associated with the femtocell base station. The mobility management entity may combine the received macrocell tracking area information with femtocell tracking area information associated with the femtocell base station and storing the combined tracking area information as integrated tracking area information.

Abstract: Described embodiments provide for handover in a long term evolution (LTE) communication network. A LTE macrocell base station may receive a measurement report from user equipment while providing a communication service to the user equipment located within a service area of the LTE macrocell base station, and determine whether or not the neighbor cell is a LTE macrocell or a LTE femtocell based on the measurement report. The LTE macrocell base station may initiate hand-over of the user equipment to a neighbor WCDMA macrocell base station when the neighbor cell is determined as the LTE femtocell.

Abstract: Provided are apparatus and method for setting a cyclic prefix length according to a type of a base station. The apparatus may include a memory, a receiver, a selector, and an inserter. The receiver may be configured to store and to manage a plurality of prefix lengths associated with base station types. The receiver may be configured to receive base station information from a base station. The selector may be configured to select a prefix length from the plurality of prefix length based on the received base station information. The inserter may be configured to insert a cyclic prefix having the determined prefix length in a guard interval of a transmission frame.